Show simple item record

dc.contributor.authorLorenzo, Paula M.
dc.contributor.authorIzquierdo, Andrea G.
dc.contributor.authorDiaz-Lagares, Angel
dc.contributor.authorCarreira, Marcos C.
dc.contributor.authorMacias-Gonzalez, Manuel
dc.contributor.authorSandoval, Juan
dc.contributor.authorCueva, Juan
dc.contributor.authorLopez-Lopez, Rafael
dc.contributor.authorCasanueva, Felipe F.
dc.contributor.authorCrujeiras, Ana B.
dc.date.accessioned2024-02-12T19:46:00Z
dc.date.available2024-02-12T19:46:00Z
dc.date.issued2020-04-23
dc.identifier.otherhttp://hdl.handle.net/10668/3904
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18035
dc.description.abstractThe methylation levels of ZNF577 in breast tumors has been previously identified as a possible epigenetic mark of breast cancer associated with obesity. The aim of the current study was to investigate differences in methylation levels of ZNF577 depending on obesity, menopausal state and dietary pattern in blood leukocytes, a non-invasive sample. The methylation levels of ZNF577 of two CpG sites (CpGs) located in promoter and island previously identified as differentially methylated according to adiposity and menopausal state by 450 k array (cg10635122, cg03562414) were evaluated by pyrosequencing in DNA from the blood leukocytes of breast cancer patients [n = 90; n = 64 (71.1%) overweight/obesity and n = 26 (28.9%) normal-weight] and paired tumor tissue biopsies (n = 8 breast cancer patients with obesity; n = 3/5 premenopausal/postmenopausal women). Differences in methylation levels were evaluated at each CpGs individually and at the mean of the two evaluated CpGs. Adherence to the Mediterranean diet was evaluated using the MEDAS-validated questionnaire, and the consumption of food groups of interest was also evaluated using the recommended intakes of the Sociedad Española de Nutricion Comunitaria. The methylation levels of ZNF577 were correlated between paired leukocytes and breast tumor biopsies (r = 0.62; p = 0.001). Moreover, higher methylation was found in leukocytes from patients with obesity (p = 0.002) and postmenopausal patients (p = 0.022) than patients with normal-weight or premenopausal, respectively. After adjusting for the body mass index and age, higher levels of ZNF577 methylation were also found in women with greater adherence to the Mediterranean diet (p = 0.017) or specific foods. Relevantly, the methylation levels of ZNF577 showed a good ability for fish consumption detection [area under the ROC curve (AUC) = 0.72; p = 0.016]. In conclusion, the association between methylation of ZNF577 and adiposity, menopausal state, and adherence to the Mediterranean diet can be detected in the blood leukocytes. The results guarantee the need of performing further studies in longer longitudinal cohorts in order to elucidate the role of ZNF577 methylation in the association between breast cancer, adiposity and dietary patterns.
dc.description.sponsorshipThis study was supported by the Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion.
dc.language.isoeng
dc.publisherFrontiers Media 
dc.type.hasVersionVoR
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEpigenetics
dc.subjectObesity
dc.subjectCancer
dc.subjectNutrition
dc.subjectBlood cells
dc.subjectBiomarkers
dc.subjectBreast neoplasms
dc.subjectMethylation
dc.subjectEpigenómica
dc.subjectObesidad
dc.subjectNeoplasias
dc.subjectCiencias de la nutrición
dc.subjectCélulas sanguíneas
dc.subjectBiomarcadores
dc.subjectNeoplasias de la mama
dc.subjectMetilación
dc.subject.meshAdiposity 
dc.subject.meshAdult 
dc.subject.meshBody Mass Index 
dc.subject.meshBreast Neoplasms 
dc.subject.meshCpG Islands 
dc.subject.meshDNA-Binding Proteins 
dc.subject.meshEpigenomics 
dc.subject.meshFemale 
dc.subject.meshFollow-Up Studies 
dc.subject.meshHumans 
dc.subject.meshLeukocytes 
dc.subject.meshMenopause 
dc.subject.meshMiddle Aged 
dc.subject.meshObesity 
dc.subject.meshPrognosis 
dc.subject.meshPromoter Regions, Genetic
dc.subject.meshSpain 
dc.subject.meshTranscription Factors 
dc.subject.meshDNA Methylation 
dc.subject.meshDiet, Mediterranean 
dc.subject.meshMethylation 
dc.titleZNF577 Methylation Levels in Leukocytes From Women With Breast Cancer Is Modulated by Adiposity, Menopausal State, and the Mediterranean Diet
dc.typeresearch article
dc.rights.licenseAttribution 4.0 International*
dc.identifier.pubmedID32390948es_ES
dc.identifier.doi10.3389/fendo.2020.00245
dc.identifier.e-issn1664-2392es_ES
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fendo.2020.00245/fulles
dc.identifier.journalFrontiers in Endocrinologyes_ES
dc.rights.accessRightsopen accesses_ES
dc.contributor.authoraffiliation[Lorenzo,PM; Izquierdo,AG; Crujeiras,AB] Laboratory of Epigenomics in Endocrinology and Nutrition (EpiEndoNut), Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS), Santiago de Compostela, Spain. [Izquierdo,AG; Carreira,MC; Macias-Gonzalez,M; Casanueva,FF; Crujeiras,AB] CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEOBN), Instituto de Salud Carlos III, Madrid, Spain. [Diaz-Lagares,A] Cancer Epigenetics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain. [Diaz-Lagares,A; Lopez-Lopez,R] CIBER de Oncologia (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. [Carreira,MC; Casanueva,FF] Laboratory of Molecular and Cellular Endocrinology, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain. [Macias-Gonzalez,M] Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, University of Malaga (IBIMA) and CIBEROBN, Málaga, Spain. [Sandoval,J] Biomarkers and Precision Medicine Unit and Epigenomics Core Facility, Health Research Institute La Fe, Valencia, Spain. [Cueva,J; Lopez-Lopez,R] Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
This item is licensed under a: Attribution 4.0 International